Ovarian Cancerfind mydrugscancerPaclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trialPhase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyConsolidation Radiotherapy After Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian CancerRisk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives. SHARE Study Group. Steroid Hormones and ReproductionsRisk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral ContraceptivesOral contraceptives and the risk of hereditary ovarian cancerIntraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Consolidation Radiotherapy After Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian Cancer
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives. SHARE Study Group. Steroid Hormones and Reproductions
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives